BioSig regains full Nasdaq compliance; delisting risk resolved as of March 24

Streamex Corp.

Nasdaq confirmed on March 24, 2025 that BioSig met the $2.5M stockholders' equity requirement for continued listing.
Company had a compliance exception through March 7, 2025; submitted evidence on March 6, 2025.
Regaining compliance removes the risk of delisting from the Nasdaq Capital Market.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.